Literature DB >> 1200759

Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression.

J W Maas.   

Abstract

Recent research findings indicate that depressive disorders may be divided into two groups, A and B, using specific biochemical and pharmacological criteria. It is suggested that in the A group there is a disorder of norepinephrine systems are not altered. Further, there is the possibility that B types patients have disorder of serotonin, but not norepinephrine or dopamine systems. This biochemical heterogeneity of human depression has implications for both investigators and clinicians, and may account for disparate findings in biological studies of patients with affective disorders.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1200759     DOI: 10.1001/archpsyc.1975.01760290025002

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  41 in total

1.  Platelets and biogenic amines. 2. Indications for a discrete low affinity uptake mechanism shared by norepinephrine and 5-hydroxytryptamine in human platelets.

Authors:  R Malmgren
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 2.  Antidepressants and serotonergic neurotransmission: an integrative review.

Authors:  P Willner
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 3.  Integrating neuroimmune systems in the neurobiology of depression.

Authors:  Eric S Wohleb; Tina Franklin; Masaaki Iwata; Ronald S Duman
Journal:  Nat Rev Neurosci       Date:  2016-06-09       Impact factor: 34.870

4.  A brief update in psychopharmacology.

Authors:  M S Rapp
Journal:  Can Fam Physician       Date:  1979-03       Impact factor: 3.275

Review 5.  Amoxapine: a review of its pharmacology and efficacy in depressed states.

Authors:  S G Jue; G W Dawson; R N Brogden
Journal:  Drugs       Date:  1982-07       Impact factor: 9.546

6.  MHPG excretion in endogenous depression: relationship to clinical state and the effects of ECT.

Authors:  M H Joseph; D Risby; T J Crow; J F Deakin; E C Johnstone; P Lawler
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

7.  Effects of mianserin in neuroleptic-induced parkinsonism.

Authors:  S Korsgaard; T Friis
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

8.  Determination of 3-methoxy-4-hydroxyphenylglycol conjugates in urine. Application to the study of central noradrenaline metabolism in unmedicated chronic schizophrenic patients.

Authors:  M H Joseph; H F Baker; E C Johnstone; T J Crow
Journal:  Psychopharmacology (Berl)       Date:  1976-12-21       Impact factor: 4.530

9.  [Endocrinological prediction of the responsiveness of depressive patients to lofepramine (author's transl)].

Authors:  M Philipp; J Beyer; J Happ; U Krause
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1979-07-04

10.  The emerging modern face of mood disorders: a didactic editorial with a detailed presentation of data and definitions.

Authors:  Konstantinos N Fountoulakis
Journal:  Ann Gen Psychiatry       Date:  2010-04-12       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.